SEC Company Response from Stablecoin Development (SDEV) — Nov 25, 2025
Stablecoin Development Corp
Date: Nov. 25, 2025 · CIK: 0001389545 · Accession: 0001437749-25-036356
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290712
Letter
nby20251125_corresp.htm
NovaBay Pharmaceuticals, Inc.
2000 Powell Street, Suite 1150
Emeryville, California 94608
(510) 899-8838
November 25, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
RE:
NovaBay Pharmaceuticals, Inc.
Registration Statement on Form S-3 (File No. 333-290712)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), hereby respectfully requests that the effective date of its Registration Statement on Form S-3 (File No. 333-290712) (the “ Registration Statement ”) be accelerated by the Securities and Exchange Commission so that it will be declared effective at 4:00 p.m. EST on November 25, 2025, or as soon as possible thereafter. The Company hereby authorizes Timothy Machat of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Timothy Machat of Ropes & Gray LLP at Timothy.Machat@ropesgray.com or (212) 596-9281.
Very truly yours,
NOVABAY PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm nby20251125_corresp.htm NovaBay Pharmaceuticals, Inc. 2000 Powell Street, Suite 1150 Emeryville, California 94608 (510) 899-8838 November 25, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 RE: NovaBay Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-290712) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), hereby respectfully requests that the effective date of its Registration Statement on Form S-3 (File No. 333-290712) (the “ Registration Statement ”) be accelerated by the Securities and Exchange Commission so that it will be declared effective at 4:00 p.m. EST on November 25, 2025, or as soon as possible thereafter. The Company hereby authorizes Timothy Machat of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Timothy Machat of Ropes & Gray LLP at Timothy.Machat@ropesgray.com or (212) 596-9281. Very truly yours, NOVABAY PHARMACEUTICALS, INC. By: /s/ Tommy Law Tommy Law Chief Financial Officer & Treasurer